AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 80 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $25,000 | +8.7% | 127,313 | +285.3% | 0.00% | – |
| Q4 2018 | $23,000 | -53.1% | 33,045 | -17.3% | 0.00% | – |
| Q3 2018 | $49,000 | -22.2% | 39,939 | +27.4% | 0.00% | – |
| Q1 2018 | $63,000 | +293.8% | 31,338 | +131.9% | 0.00% | – |
| Q4 2017 | $16,000 | -59.0% | 13,514 | -56.2% | 0.00% | – |
| Q3 2017 | $39,000 | -53.6% | 30,843 | -51.2% | 0.00% | – |
| Q2 2017 | $84,000 | -33.9% | 63,243 | -6.9% | 0.00% | – |
| Q1 2017 | $127,000 | -94.7% | 67,912 | -85.2% | 0.00% | -100.0% |
| Q4 2016 | $2,382,000 | – | 459,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|